Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1

Conditions

Sarcopenia 1Prediabetic State 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neoplasms 1Myelodysplastic Syndromes 1Muscle Weakness 1Leukemia, Myeloid 1Hematologic Neoplasms 1Heart Failure 1Head and Neck Neoplasms 1Endometrial Neoplasms 1Cardiotoxicity 1Breast Neoplasms 1Anemia, Aplastic 1

Interventions

Paclitaxel 95Carboplatin 77pembrolizumab 74Cisplatin 29Bevacizumab 27Surveys and Questionnaires 23Radiotherapy 22Letrozole 22Doxorubicin 21Megestrol Acetate 20olaparib 19lenvatinib 19Taxes 17Specimen Handling 17Docetaxel 17Nivolumab 16Magnetic Resonance Spectroscopy 16dostarlimab 15Metformin 15Blood Specimen Collection 14Observation 13Gemcitabine 13Biopsy 13durvalumab 12Medroxyprogesterone Acetate 12Trastuzumab 11Indocyanine Green 11Fulvestrant 11temsirolimus 10abemaciclib 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × nicotinamide-beta-riboside × Clear all
NCT03642990 2023-04-12

NR in Chemo-induced Peripheral Neuropathy

University of Iowa

Phase 2 Terminated
5 enrolled 11 charts
GynecologicHead & Neck

Head and Neck Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡